UK Biocentre has expanded its sample storage capacity with the addition of Azenta's BioArc Ultra, ad...
Rigel Pharmaceuticals has announced the enrolment of the first patient in a Phase I trial evaluating...
Rigel Pharmaceuticals has announced the enrolment of the first patient in a Phase I trial evaluating...
UK Biocentre has expanded its sample storage capacity with the addition of Azenta's BioArc Ultra, adding space for 16 million more samples to support vital health research. ...
Rigel Pharmaceuticals has announced the enrolment of the first patient in a Phase I trial evaluating fostamatinib for sickle cell disease. ...
Rigel Pharmaceuticals has announced the enrolment of the first patient in a Phase I trial evaluating fostamatinib for sickle cell disease....
Cancer Research UK, Cytovation, and the Norwegian Cancer Society have teamed up to advance the treatment of adrenocortical carcinoma (ACC). The collaboration will support the Phase II clinical trial o...
Unlock Exclusive Industry Insights
